How many drugs treat Postpartum hemorrhage?

Drug Landscape tracks 6 marketed treatments for Postpartum hemorrhage (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/postpartum-hemorrhage.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Postpartum hemorrhage — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postpartum hemorrhage (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Postpartum hemorrhage, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cytotec	misoprostol	Generic (originally Searle/Pfizer)	Prostaglandin E1 analog	Prostaglandin E2 receptor EP2 subtype, Prostaglandin E2 receptor EP3 subtype, Prostaglandin E2 receptor EP4 subtype	1988-12-27
Oxytocin 5 Usp Units In Dextrose 5%	OXYTOCIN	Fresenius Kabi	Adrenocorticotropic Hormone [EPC]	Oxytocin receptor	1980-01-01
Hemabate	CARBOPROST	Pfizer	Prostaglandin Analog	Prostaglandin F2-alpha receptor	1979-01-01
Methergine	methylergometrine	Edison Theraps Llc	Ergot Derivative	5-hydroxytryptamine receptor 2A	1946-01-01
Ergobasine	Ergometrine	Cairo University	ergometrine	5-hydroxytryptamine receptor 1D
Methergine	Methergine	University of South Florida		5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 1A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 2 drugs in Postpartum hemorrhage
Cairo University · 1 drug in Postpartum hemorrhage
Edison Theraps Llc · 1 drug in Postpartum hemorrhage
Fresenius Kabi · 1 drug in Postpartum hemorrhage
Generic (originally Searle/Pfizer) · 1 drug in Postpartum hemorrhage
University of South Florida · 1 drug in Postpartum hemorrhage

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Postpartum hemorrhage:

Cite this brief

Drug Landscape (2026). Postpartum hemorrhage — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/postpartum-hemorrhage. Accessed 2026-06-10.

Postpartum hemorrhage full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing